Eight configurational 1-deoxynojirimycin isomers have been synthesized starting from a chiral cyanohydrin as the common precursor. The cyanohydrin chiral pool building block is easily accessible in large quantities by using almond hydroxynitrile lyase as the chiral catalyst in condensing hydrogen cyanide and crotonaldehyde. Our work complements the
Introduction
Hydroxynitrile lyases (HNLs), also known as oxynitrilases, have attracted great interest from the synthetic organic chemistry community for more than a century. The first use of a HNL derived from almonds (paHNL) was reported by Rosenthaler in 1908 . [1] In 1965 a range of optically active cyanohydrins, starting from both aromatic and aliphatic aldehydes, were synthesized by Becker and Pfeil, who used a buffered aqueous ethanol mixture as the solvent. [2, 3] These early results demonstrated for the first time the potential of paHNL in the construction of chiral compounds, although the highest ee reported was 87 %. [2] Further significant progress was made in 1987 when Effenberger et al. reported the synthesis of (R)-mandelonitrile, catalysed by paHNL. By performing the reaction in a two-phase system, they obtained (R)-mandelonitrile in 99.3 % ee and 95 % yield. [4] Since then, the role of HNLs in organic synthesis has gradually grown and today they are an important synthetic tool in the production of a wide range of both (R)-and (S)-cyanohydrins with high enantioselectivity and high yields. [5] The versatility of cyanohydrins as optically active building blocks in synthetic chemistry has been widely investi-large body of literature on the synthesis of 1-deoxynojirimycin derivatives with the distinguishing feature that eight stereoisomers of this important class of glycosidase inhibitors can be derived from a common precursor in an efficient manner.
gated. We have reported on a number of conversions involving cyanohydrins that lead to valuable chiral building blocks. [5] For example, (2R,3E)-2-hydroxypent-3-enenitrile (1), derived from crotonaldehyde and HCN can be prepared in 99 % enantiomeric purity by using either purified paHNL [6] or defatted almond meal containing the enzyme (Scheme 1). [7] (2R,3E)-2-Hydroxypent-3-enenitrile bears three individual functionalities that can be addressed independently. In the unprotected form it has been used in the synthesis of α-hydroxy esters, [8] α-hydroxy acids [9] and vicinal diols. [10] The protected forms can be used to produce chiral nitrones, [11] cyclic 1,2-ethanolamines, [12] chiral piperidinols, [12] α-hydroxy-β-amino acids, [13] tetronic acids [14] and 1,2-ethanolamines. [15] Scheme 1. Preparation of cyanohydrins 1 and 2. Reagents and conditions: a) HCN, EtOAc, 0.1 m aq. citrate buffer, pH 5.4, paHNL; b) TBDPS-Cl, imidazole, DMF, 0°C Ǟ room temp.
Recently we reported on the synthesis of two new orthogonally protected building blocks for the stereoselective synthesis of 1-deoxynojirimycin (1-DNJ) isomers. [16] Starting from cyanohydrin 2, building blocks 6 and 7 were obtained after a three-step synthesis, as depicted in Scheme 2. Cyanohydrin 2 was converted into secondary amines 3 and 4 in a one-pot DIBAL-H reduction/transimination/NaBH 4 reduction sequence [17] employing either (R)-benzyloxyvinylglycinol [(R) -5] or (S)-benzyloxyvinylglycinol [(S) -5] in the transimination step. [16] Subsequent N-Boc protection and ring-closing metathesis readily afforded 6 and 7 in overall yields of 72 %. We anticipated that compounds 6 and 7 would be good starting materials in the synthesis of a number of the 16 possible 1-DNJ isomers by oxidation of the double bond present in 6 and 7. We demonstrated the validity of this reasoning through the synthesis of d-allo-and d-galacto-1-DNJ (12 and 13) from 6 (Scheme 3) and the preparation of l-altro-1-DNJ (20) from 7 (Scheme 4). [16] As part of an ongoing program to synthesize new potential inhibitors of enzymes involved in the glycosylceramide metabolism [18] we report herein the synthesis of eight configurational isomers of 1-deoxynojirimycin, more specifically, all the isomers featuring a 3,4-cis-diol moiety. [19] 
Results and Discussion
To synthesize the d-1-DNJ isomers, as depicted in Scheme 3, the trans-substituted cyclic compound 6 served as the starting material. By means of an Upjohn dihydroxylation reaction, diols 8 and 9 were obtained in a 1:1 ratio, as determined by LC-MS. The mixture was separated by careful silica gel column chromatography to afford 8 and 9 in equal amounts. Subsequent removal of the TBDPS group followed by catalytic hydrogenation under acidic conditions afforded d-allo-and d-galacto-1-DNJ (12 and 13) in high yields. [16] All the spectral and analytical data are in agreement with those reported in the literature. [20, 21] To prepare d-talo-1-DNJ (16), the protected galacto-1-DNJ (9) served as the starting compound. The 3,4-cis-diol was protected as the acetonide and subsequently the TBDPS group was removed to give alcohol 14. An attempted Mitsunobu reaction on 14 failed and the starting material was recovered. Hence, the free hydroxy in 14 was oxidized to the corresponding ketone after which NaBH 4 reduction at -75°C afforded 15 as the sole product in 69 % yield over the two steps. Catalytic hydrogenation of 15 under acidic conditions afforded d-talo-1-DNJ (16) in quantitative yield (Scheme 3). To prepare d-altro-1-DNJ (18) from compound 6, we turned to an approach in which the silyl protection in 6 was removed and the resulting alcohol was subjected to a Mitsunobu reaction at 0°C. In this way the benzoic ester of compound 17 was obtained as an inseparable mixture of two diastereoisomers in a ratio of 85:15. Decreasing the starting temperature of the Mitsunobu reaction to -70°C and subsequent warming to room temperature improved the diastereoselectivity to 98:2. Retaining the temperature at -75°C for 12 h, followed by slow warming to room temperature afforded the benzoate of 17 as a single diastereoisomer, as determined by RP-HPLC. Unfortunately, we could not separate the benzoate of 17 completely from the side-products of the Mitsunobu reaction. However, subsequent saponification afforded the pure alcohol 17 in 87 % yield. Note that alcohol 17 with a 2S,5S configuration is separable from the 2S,5R diastereoisomer by column chromatography. Alcohol 17 was subjected to Upjohn dihydroxylation, [23] which afforded a single stereoisomeric compound in 82 % yield.
Comparison of the NMR and optical rotation data of 17 with the earlier prepared l isomer revealed that indeed the N-Boc-2-OBn-protected d-altro-1-DNJ had been obtained. Hydrogenation under acidic conditions gave d-altro-1-DNJ (18) in 80 % yield over two steps and in 70 % overall yield based on starting compound 6. The analytical and spectroscopic data are in complete agreement with literature data.
[24]
1-Deoxynojirimycin Isomers from a Single Chiral Cyanohydrin
The enantiomers of the four 1-DNJ isomers presented above are accessible from building block 7 in a similar fashion. Direct dihydroxylation of compound 7 afforded diol 19 exclusively. Desilylation using TBAF and subsequent catalytic hydrogenation under acidic conditions gave l-altro-1-DNJ (20) [25] in an overall yield of 75 % over the three steps (Scheme 4). [16] Scheme 4. Preparation of l-1-deoxynojirimycin isomers from precursor 7. Reagents and conditions: a) TBAF, THF, 18 h; b) Ph 3 Compound 7 was transformed into trans-substituted building block 21 by a three-step procedure that involved removal of the TBDPS group, Mitsunobu substitution with benzoic acid and subsequent saponification. Dihydroxylation of 21 led to an inseparable mixture of the diols 22 and 23 in a ratio of 4:1. Therefore we deemed it necessary to re-install a TBDPS group on 21 to obtain compound 24 in almost quantitative yield. Unfortunately, we were unable to completely remove the impurities resulting from the silyl protection reaction. Nonetheless, compound 24 was subjected to Upjohn dihydroxylation and in this way protected l-allo-1-DNJ (25) [26] and l-galacto-1-DNJ (26) [27] were obtained in a ratio of around 1:1. After separation by column chromatography and two deprotection steps, l-allo-1-DNJ (27) and l-galacto-1-DNJ (28) were obtained in high yields. By protecting the diol in 26 as an acetonide and subsequent removal of the TBDPS group, we obtained alcohol 29. This alcohol was converted into the corresponding ketone by Dess-Martin oxidation and after a completely selective NaBH 4 reduction and complete deprotection by catalytic hydrogenation under acidic conditions we obtained l-talo-1-DNJ (30) [28] in 62 % yield after three steps.
Conclusions
We have successfully synthesized a pallet of eight 1-deoxynojirimycin isomers out of the 16 possible isomers, all starting from the common precursor cyanohydrin 2. The process involved transformation of 2 into the cyclic building blocks 6 and 7 in overall yields of 76 %. Compound 6 was converted into d-1-DNJ isomers 12 and 13 (36 % overall, three steps), 16 (20 %, six steps) and 18 (71 %, five steps). Building block 7 provided the l-1-DNJ isomers 20 (75 %, three steps), 27 and 28 (29 and 25 %, respectively, seven steps) and 30 (14 %, ten steps). The chemistry described above renders compounds 6 and 7 valuable extensions to the already known strategies for the synthesis of 1-DNJ derivatives and its analogues from chiral pool carbohydrates [29] and de novo synthetic strategies, [24a,30] often from chiral building blocks.
[31] We are currently investigating the potential of using orthogonally protected iminosugars 8, 9, 15, 19, 25 and 26 as starting points in the synthesis of the other eight 1-DNJ isomers.
Experimental Section
Compounds 1-13: Detailed experimental procedures for the synthesis of compounds 1, [12] 2 [12] and 3-13 [16] have been reported previously.
tert-Butyl (2R,3S,4R,5S)-2-(Benzyloxymethyl)-3,4-O-isopropylidene-5-(tert-butyldiphenylsilyloxy)piperidine-1-carboxylate: Diol 9 (800 mg, 1.69 mmol) was dissolved in a mixture of THF (20 mL) and 2,2-dimethoxypropane (2.00 mL). A few crystals of p-toluenesulfonic acid were added and the mixture was stirred at room temperature overnight. TLC analysis showed complete conversion and the mixture was diluted with EtOAc and washed with an aqueous solution of NaHCO 3 and brine. Drying (Na 2 SO 4 ), filtration and evaporation of the solvent gave a crude product that was purified by silica gel column chromatography (PE/EtOAc, 96:4 Ǟ 90:10) to afford the target compound as a colourless oil (764 mg, 72 % tert-Butyl (2S,5R)-2-(Benzyloxymethyl)-5,6-dihydro-5-hydroxypyridine-1(2H)-carboxylate: Silyl ether 6 (2.20 g, 3.95 mmol) was dissolved in THF (25 mL) and cooled to 0°C after which a 1 m solution of TBAF (6.00 mL, 6.00 mmol) was added dropwise. The mixture was warmed to room temperature and stirred overnight. It was then diluted with EtOAc (200 mL), washed with water (25 mL) and brine (25 mL), dried (MgSO 4 ), filtered and concentrated to afford the crude product, which was purified by silica gel column chromatography (PE/EtOAc, 4:1 Ǟ 7:3 Ǟ 3:2) to afford the product as a clear colourless oil (1.19 
tert-Butyl (2S,5S)-5-(Benzoyloxy)-2-(benzyloxymethyl)-5,6-dihydropyridine-1(2H)-carboxylate:
A solution of the previous alcohol (1.19 g, 3.73 mmol), triphenylphosphane (1.17 g, 4.46 mmol) and benzoic acid (0.741 g, 6.07 mmol) in THF (20 mL) was cooled to -75°C at which temperature a solution of diethyl azodicarboxylate (0.784 g, 4.51 mmol) in THF (7 mL) was dropwise over 1 h. Stirring was continued at -75°C for 12 h after which the temperature was slowly raised to room temperature over 5 h. TLC analysis confirmed complete conversion of the starting alcohol and the reaction mixture was diluted with EtOAc (100 mL) and washed with 1 m HCl (10 mL), an aqueous saturated solution of NaHCO 3 (25 mL) and brine (25 mL). The organic layer was dried (MgSO 4 ), filtered and concentrated to afford the crude product, which was purified by silica gel column chromatography (PE/EtOAc, 95:5 Ǟ 90:10) to afford the product as a clear colourless oil (1.57 g, 100 % and 6 m HCl (6 mL). The solution was purged with nitrogen after which Pd/C (10 %, 60 mg) was added and the reaction mixture was stirred under a balloon of H 2 overnight. The mixture was filtered through a Whatman ® glass-fibre filter and concentrated to afford the title compound as a white solid (310 mg, quant. and benzoic acid (0.736 g, 6.03 mmol) was dissolved in THF (20 mL). At -75°C a solution of DEAD (0.690 mL, 4.44 mmol) in THF (7 mL) was added dropwise over 10 min. After stirring at -75°C for 12 h, the mixture was slowly warmed to room temperature. TLC analysis revealed complete conversion and the reaction mixture was diluted with EtOAc (100 mL) and then washed with aqueous 0.5 m HCl (20 mL), saturated aqueous NaHCO 3 (20 mL) and brine (20 mL). After drying (MgSO 4 ), filtration and concentration in vacuo, the crude product was obtained. At this stage RP-HPLC analysis indicated Ͻ1 % of the 2S,5R isomer in the crude product. Purification by silica gel column chromatography (PE/ EtOAc, 95:5 Ǟ 90:10) afforded the product as a clear colourless oil 
tert-Butyl (2R,5S)-2-(Benzyloxymethyl)-5,6-dihydro-5-hydroxypyridine-1(2H)-carboxylate (21):
The benzoate from above (1.67 g, 3.94 mmol) was dissolved in a mixture of MeOH (100 mL) and water (20 mL). Subsequently aqueous 4 m NaOH (10 mL) was added at 0°C. The reaction mixture was warmed up to room temperature and after 3 h TLC analysis revealed complete conversion of the starting material. The reaction mixture was concentrated to a quarter of its volume and diluted with EtOAc (200 mL), washed with brine (2 ϫ 50 mL), dried (MgSO 4 ), filtered and concentrated. 
